India, the second-largest exporter of over-the-counter and prescription drugs to the United States, is coming under increased scrutiny by American regulators for safety lapses, falsified drug tests and selling fake medicines, reports [s]The New York Times[/s].
[b]Dr Margaret Hamburg[/b], the commissioner of the [b]US Food and Drug Administration[/b], arrived in India this week to express her growing unease with the safety of Indian medicines because of ‘recent lapses in quality’. India’s pharmaceutical industry supplies 40 percent of over-the-counter and generic prescription drugs consumed in the US, so the increased scrutiny could have profound implications for American consumers.
[link url=http://www.nytimes.com/2014/02/15/world/asia/medicines-made-in-india-set-off-safety-worries.html?nl=todaysheadlines&emc=edit_th_20140215&_r=0]Full report in The New York Times[/link]